Comparison of RNA-seq and microarray-based models for clinical endpoint predictionWenqian Zhang, Carolina Rosswog, Viswanath Devanarayan et al.|Genome Biology|2015Cited by 429
Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Clinical Cancer Research|2014Cited by 99
Antibody targeting of anaplastic lymphoma kinase induces cytotoxicity of human neuroblastomaE L Carpenter, Y P Mossé, E A Haglund et al.|Oncogene|2012Cited by 64
Supplementary Data 1 from Revised Risk Estimation and Treatment Stratification of Low- and Intermediate-Risk Neuroblastoma Patients by Integrating Clinical and Molecular Prognostic MarkersAndré Oberthuer, Matthias Fischer, Dilafruz Juraeva et al.|Unknown|2023Cited by 0